Morphic Holding (MORF) Stock Highlights

56.99 | +0%

2024-12-21 03:06:37

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.

Statistics

Range Today

56.99 56.99

Volume Today 0

Range 1 Year

19.34 57

Volume 1 Year 287.38M

Range 3 Year

19.23 68.75

Volume 3 Year 454.92M

Range 10 Year

9.9 93

Volume 10 Year 533.48M

Highlights

Market Capitalization 2.86B (mid)

Floating Shares 33.9M

Current Price 56.99

Price To Earnings 0

Price To Book 4.62

Earnings Per Share -3.83

Payout Ratio 0%

Performance

Latest 0%

1 Month +1.86%

3 Months +89.15%

6 Months +49.23%

1 Year +6.82%

3 Years -5%

5 Years +172.42%

10 Years +216.61%

Benchmarks

Market Capitalization

84 / 368

Gross Profits

178 / 278

Total Revenue

196 / 300

Total Rank

204 / 368

Free Cashflow

239 / 352

Performance 5 years

43 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.